Specific code 2015 ICD-9-CM Diagnosis Code V07.51
Use of selective estrogen receptor modulators (SERMs)
  • 2015
  • Billable Thru Sept 30/2015
  • Non-Billable On/After Oct 1/2015

  • ICD-9-CM V07.51 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, V07.51 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Convert to ICD-10-CM: V07.51 converts directly to:
  • 2015/16 ICD-10-CM Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
Applies To
  • Use of:
    • raloxifene (Evista)
    • tamoxifen (Nolvadex)
    • toremifene (Fareston)
ICD-9-CM Volume 2 Index entries containing back-references to V07.51:
  • Long-term (current) (prophylactic) drug use V58.69
    • tamoxifen V07.51
  • Use of
    • raloxifene (Evista) V07.51
    • selective estrogen receptor modulators (SERMs) V07.51
    • tamoxifen (Nolvadex) V07.51
    • toremifene (Fareston) V07.51
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM V07.51 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2015 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.